Acerus Pharmaceuticals Archives

Press ESC key to close search

Acerus Pharmaceuticals Files for CCAA Protection

Acerus Pharmaceuticals and its subsidiaries, Acerus Biopharma, Acerus Labs and Acerus Pharmaceuticals USA, have received an order for creditor protection from the Ontario Superior Court of Justice under the Companies’ Creditors Arrangement Act (the CCAA).

First Generation Capital Provides $2.1MM Increase to Facility with Acerus Pharmaceuticals

Acerus Pharmaceuticals entered into an amending agreement with First Generation Capital, a company affiliated with the chairman of the board of directors of Acerus, to increase its existing secured loan facility from $35.8 million to $37.9 million.

June 27, 2022 Acerus Pharmaceuticals | First Generation Capital Ian Koplin

SWK Amends Acerus Pharmaceuticals’ Existing Credit Facility

Acerus Pharmaceuticals entered into an amended agreement related to its existing credit facility with SWK, changing four aspects of its terms and conditions.

March 26, 2021 Acerus Pharmaceuticals | SWK Holdings Ian Koplin

First General Provides $5MM Term Loan for Acerus

Acerus Pharmaceuticals has entered into a $5 million subordinated secured term loan facility with First Generation Capital

July 22, 2019 Acerus Pharmaceuticals | First Generation Capital nadine

<img width="200" src="https://www.abfjournal.com/wp-content/uploads/2020/02/abfj-logo-web-header1-blue.png" alt="ABFJournal" />

Tag Archives: Acerus Pharmaceuticals

Acerus Pharmaceuticals Files for CCAA Protection

First Generation Capital Provides $2.1MM Increase to Facility with Acerus Pharmaceuticals

SWK Amends Acerus Pharmaceuticals’ Existing Credit Facility

First General Provides $5MM Term Loan for Acerus